RS/EHRA Expert Consensus on the Monitoring of Cardiovascular mplantable Electronic Devices (CIEDs): Description of Techniques, ndications, Personnel, Frequency and Ethical Considerations

1 C RS/EHRA Expert Consensus on the Monitoring of Cardiovascular mplantable Electronic Devices (CIEDs): Description of Techniques, ndications, Personnel, Frequency and Ethical Considerations eveloped in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm ssociation (EHRA); and in collaboration with the American College of Cardiology (ACC), the merican Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure ssociation of ESC (HFA), and the Heart Failure Society of America (HFSA). ndorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered ranch of the ESC), the American College of Cardiology, the American Heart Association.

[1]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[2]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[3]  B. Furrow.  Bioethics : health care law and ethics , 2008 .

[4]  T. England,et al.  The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer , 2007, Journal of Medical Ethics.

[5]  R. Kobza,et al.  End‐of‐life Decisions in ICD Patients with Malignant Tumors , 2007, Pacing and clinical electrophysiology : PACE.

[6]  L. Saxon,et al.  Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale. , 2007, Journal of cardiac failure.

[7]  B. Lindsay,et al.  NATIONAL ICD REGISTRY ANNUAL REPORT 2006 Review of the Registry's First Year, Data Collected, and Future Plans , 2007 .

[8]  L. Wilkins.  ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures , 2006 .

[9]  O. Costantini,et al.  Withdrawing implantable defibrillator shock therapy in terminally ill patients. , 2006, The American journal of medicine.

[10]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[11]  European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  L. Jordaens,et al.  The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies , 2006, Clinical Research in Cardiology.

[13]  P. Adragao,et al.  National Registry on Cardiac Electrophysiology--2004. , 2006, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[14]  M Santini,et al.  Management of atrial fibrillation--what are the possibilities of early detection with home monitoring? , 2006, Clinical research in cardiology : official journal of the German Cardiac Society.

[15]  P. Moceri,et al.  [Local registry of pacemakers implantations: proposals to decrease the infectious risk]. , 2006, Annales de cardiologie et d'angeiologie.

[16]  S. Sack,et al.  Predicting mortality and rehospitalization in heart failure patients with Home Monitoring— , 2006, Clinical Research in Cardiology.

[17]  P. Brugada.  What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? , 2006, Clinical Research in Cardiology.

[18]  J. Berger.  The Ethics of Deactivating Implanted Cardioverter Defibrillators , 2005, Annals of Internal Medicine.

[19]  D. Reynolds,et al.  Sophisticated Remote Implantable Cardioverter‐Defibrillator Follow‐Up: A Status Report , 2005, Pacing and clinical electrophysiology : PACE.

[20]  Michel Chauvin,et al.  Potential Cost Savings by Telemedicine‐Assisted Long‐Term Care of Implantable Cardioverter Defibrillator Recipients , 2005, Pacing and clinical electrophysiology : PACE.

[21]  H. Krumholz,et al.  Management of Implantable Cardioverter Defibrillators in End-of-Life Care , 2004, Annals of Internal Medicine.

[22]  J. Burkhardt,et al.  Remote Interrogation and Monitoring of Implantable Cardioverter Defibrillators , 2004, Journal of Interventional Cardiac Electrophysiology.

[23]  Gordon Crowley.  EU and US clinical investigation adverse event reporting. , 2004, Medical device technology.

[24]  D. Weiss,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[25]  W. Konertz,et al.  Quality management system of a university cardiac surgery department according to DIN EN ISO 9001 : 2000. , 2003, The Thoracic and cardiovascular surgeon.

[26]  Charles R Kerr,et al.  Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. , 2003, The Canadian journal of cardiology.

[27]  Maria Donawa.  Update on ISO 13485. , 2002, Medical device technology.

[28]  J. Maloney,et al.  The Role(s) of the Industry Employed Allied Professional , 2001, Pacing and clinical electrophysiology : PACE.

[29]  G. Breithardt,et al.  Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow‐up of Implantable Cardioverter Defibrillators , 2001, Pacing and clinical electrophysiology : PACE.

[30]  M. Schoenfeld.  Deciding Against Defibrillator Replacement: Second‐Guessing the Past? , 2000, Pacing and clinical electrophysiology : PACE.

[31]  M. Gerrity,et al.  Patients' knowledge of options at the end of life: ignorance in the face of death. , 2000, JAMA.

[32]  T. Quill,et al.  Seven legal barriers to end-of-life care: myths, realities, and grains of truth. , 2000, JAMA.

[33]  Assisted Suicide Compared with Refusal of Treatment: A Valid Distinction? , 2000, Annals of Internal Medicine.

[34]  A. Gillis,et al.  Guidelines for pacemaker follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. , 2000, The Canadian journal of cardiology.

[35]  M Donawa.  Medical device directive: preparing for the amendments. , 2000, Medical device technology.

[36]  D. Wyse,et al.  Cardiac pacemakers and implantable defibrillators in terminal care. , 1999, Journal of pain and symptom management.

[37]  L. Gostin.  Deciding life and death in the courtroom. From Quinlan to Cruzan, Glucksberg, and Vacco--a brief history and analysis of constitutional protection of the 'right to die'. , 1997, JAMA.

[38]  K. Lurie,et al.  Termination of Implantable Pacemaker Therapy: Experience in Five Patients , 1997, Annals of Internal Medicine.

[39]  R. Kaplan,et al.  Do Physicians' Own Preferences for Life-Sustaining Treatment Influence Their Perceptions of Patients' Preferences? A Second Look , 1997, Cambridge Quarterly of Healthcare Ethics.

[40]  N. Anselmann.  The European legislation on medical devices. , 1996, Studies in health technology and informatics.

[41]  R. Kaplan,et al.  Do Physicians’ Own Preferences for Life-Sustaining Treatment Influence Their Perceptions of Patients’ Preferences? , 1993, The Journal of Clinical Ethics.

[42]  C. Akinsanya.  Cancer pain relief and palliative care , 1992 .

[43]  S. Quintana,et al.  Guidelines for the appropriate use of do-not-resuscitate orders. , 2005, Journal of the Tennessee Medical Association.

[44]  R. Uhlmann,et al.  Perceived quality of life and preferences for life-sustaining treatment in older adults. , 1991, Archives of internal medicine.

[45]  F E Samuel.  Safe Medical Devices Act of 1990 , 1991, Health affairs.

[46]  Michael Bilitch,et al.  North American Society of Pacing and Electrophysiology (NASPE) , 1979, Pacing and clinical electrophysiology : PACE.